Propylene glycol 40% in Clobetasone 0.05% cream
Requires a prescription from a doctor or prescriber
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing all 26 studies.
Reviews & meta-analyses: 4 · 2019–2024
Showing all 26 studies, sorted by most relevant.
Yang Wei, Zhongping Yu, K. Lin, et al.
Food Hydrocolloids, 2019
Lei Dai, Shufang Yang, Yang Wei, et al.
Food chemistry, 2019
- Alginates
- Colloids
- Emulsions
M. Pemberton, I. Kimber
Regulatory toxicology and pharmacology : RTP, 2023
- Cosmetics
- Dermatitis, Allergic Contact
- Allergens
Propylene glycol (PG) has widespread use in pharmaceuticals, cosmetics, fragrances and personal care products. PG is not classified as hazardous under the Globally Harmonised System of Classification and Labelling of Chemicals (GHS) but poses an intriguing scientific and regulatory conundrum with respect to allergic contact dermatitis (ACD), the uncertainty being whether and to what extent PG has the potential to induce skin sensitisation. In this article we review the results of predictive tests for skin sensitisation with PG, and clinical evidence for ACD. Patch testing in humans points to PG having the potential to be a weak allergen under certain conditions, and an uncommon cause of ACD in subjects without underlying/pre-disposing skin conditions. In clear contrast PG is negative in predictive toxicology tests for skin sensitisation, including guinea pig and mouse models (e.g. local lymph node assay), validated in vitro test methods that measure various key events in the pathway leading to skin sensitisation, and predictive methods in humans (Human Repeat Insult Patch and Human Maximisation Tests). We here explore the possible scientific basis for this intriguing inconsistency, recognising there are arguably no known contact allergens that are universally negative in, in vitro, animal and human predictive tests methods.
Abstract licence: CC BY
Fan Zhang, X. Nan, Hui Wang, et al.
Animals : an Open Access Journal from MDPI, 2020
With the improvement in the intense genetic selection of dairy cows, advanced management strategies, and improved feed quality and disease control, milk production level has been greatly improved. However, the negative energy balance (NEB) is increasingly serious at the postpartum stage because the intake of nutrients cannot meet the demand of quickly improved milk production. The NEB leads to a large amount of body fat mobilization and consequently the elevated production of ketones, which causes metabolic diseases such as ketosis and fatty liver. The high milk production of dairy cows in early lactation aggravates NEB. The metabolic diseases lead to metabolic disorders, a decrease in reproductive performance, and lactation performance decline, seriously affecting the health and production of cows. Propylene glycol (PG) can alleviate NEB through gluconeogenesis and inhibit the synthesis of ketone bodies. In addition, PG improves milk yield, reproduction, and immune performance by improving plasma glucose and liver function in ketosis cows, and reduces milk fat percentage. However, a large dose of PG (above 500 g/d) has toxic and side effects in cows. The feeding method used was an oral drench. The combination of PG with some other additives can improve the effects in preventing ketosis. Overall, the present review summarizes the recent research progress in the impacts of NEB in dairy cows and the properties of PG in alleviating NEB and reducing the risk of ketosis.
Abstract licence: CC BY
J. Okolie
iScience, 2022
J. Akram, N. Akbar
Scientific Reports, 2023
The main focus of this article is to mathematically formulate the microfluidics-based mechanical system for nanofluids. A 50:50 mixture of propylene glycol (PG) and water is used as a heat transfer fluid because of its tremendous anti-freezing properties, and nontoxicity and it is safe to be utilized at the domestic level. Titanium dioxide (titania) nanoparticles are suspended in the working fluid to enhance its heat transfer ability. The fluid flow is induced by electroosmosis in a microtube, which is further assisted by cilia beating. The impacts of Joule heating and non-linear thermal radiation are also considered. The simplification of the dimensionless system is done under lubrication theory and the Debye-Hückel linearization principle. The nonlinear system of equations is executed for a numerical solution by adopting the symbolic mathematical software Maple 17 using the command "dsolve" along with the additional command "numeric" to get the numerical solution. This command utilizes a low-ordered method along with accuracy-enhancing schemes such as the deferred correction technique and Richardson extrapolation to get a numerical answer of desired accuracy, where we can choose the accuracy level and mesh points according to our requirements. The detailed analysis of results obtained from the numerical treatment of the considered problem indicates that the efficiency of the PG + water enhances due to the suspension of the nanoparticles and heat is rapidly removed from the system. Further, the velocity of the fluid is augmented by decreasing the thickness of the electric double layer and raising the strength of the electric field in the forwarding direction.
Abstract licence: CC BY
Xinyue Zhang, Wenjie Zou, Minquan Xia, et al.
Food chemistry, 2021
- Red Meat
- Pork Meat
- Alginates
Wenjie Zou, Fayez Khalaf Mourad, Xinyue Zhang, et al.
Food Hydrocolloids, 2020
M. Gatti, N. Nichio, F. Pompeo
Reactions, 2022
Humanity’s growing dependence on non-renewable resources and the ensuing environmental impact thus generated have spurred the search for alternatives to replace chemicals and energy obtained from petroleum derivatives. Within the group of biofuels, biodiesel has managed to expand worldwide at considerable levels, going from 20 million tn/year in 2010 to 47 million tn/year in 2022, boosting the supply of glycerol, a by-product of its synthesis that can be easily used as a renewable, clean, low-cost raw material for the manufacture of products for the chemical industry. The hydrogenolysis of glycerol leads to the production of glycols, 1,2-propylene glycol (1,2-PG) and 1,3-propylene glycol (1,3-PG). In particular, 1,3-PG has the highest added value and has multiple uses including its application as an additive in the polymer industry, the manufacture of cosmetics, cleaning products, cooling liquids, etc. This review focuses on the study of the hydrogenolysis of glycerol for the production of 1,3-PG, presenting the main reaction mechanisms and the catalysts employed, both in liquid and vapor phase. Engineering aspects and the effect of the operating variables to achieve maximum yields are discussed. Finally, studies related to the stability and the main deactivation mechanisms of catalytic systems are presented.
Abstract licence: CC BY
Xinyue Han, Xiaobin Chen, Yao Sun, et al.
Energy, 2020
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.